Related Experiment Video
Updated: Feb 19, 2026

11:10
Protein-protein Interactions Visualized by Bimolecular Fluorescence Complementation in Tobacco Protoplasts and Leaves
Published on: March 9, 2014
21.9K
Visualization of Protein Interactions in Living Cells Using Bimolecular Luminescence Complementation (BiLC)
Lisette G G C Verhoef1, Mark Wade1
1Center for Genomic Science of IIT@SEMM, Fondazione Istituto Italiano di Tecnologia, Milan, Italy.
Current Protocols in Protein Science
|November 2, 2017
Summary
This study details bimolecular luminescence complementation (BiLC) assays for tracking protein-protein interactions (PPIs) within cells. BiLC technology was used to discover small molecules that can modulate these crucial cellular interactions.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- Intracellular protein-protein interactions (PPIs) are crucial for cellular functions and homeostasis.
- Dysregulated PPIs are implicated in various diseases and therapeutic resistance, making them potential drug targets.
- Monitoring dynamic PPIs is essential for understanding cellular processes and disease mechanisms.
Purpose of the Study:
- To describe the selection and development of bimolecular luminescence complementation (BiLC) assays.
- To demonstrate the application of BiLC assays for reporting intracellular PPIs.
- To showcase the use of BiLC in identifying small molecules that modulate PPIs.
Main Methods:
- Utilized bimolecular complementation technology, splitting a molecular reporter into two fragments.
- Fused reporter fragments to interacting proteins, reconstituting reporter activity upon PPI.
- Developed and applied bimolecular luminescence complementation (BiLC) assays to study intracellular PPIs.
Main Results:
- Successfully established BiLC assays for reporting intracellular PPIs.
- Demonstrated the utility of BiLC in identifying small molecules capable of modulating PPIs.
- Provided examples of BiLC application in drug discovery efforts.
Conclusions:
- BiLC is an effective technology for monitoring intracellular PPIs.
- BiLC assays can be employed to discover modulators of PPIs.
- This approach holds promise for identifying novel therapeutic targets and drugs.

